United States · FDA National Drug Code directory
Nucala
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0173-0881_869b75ba-b2a0-406e-9ed2-136b75763d78
- Product NDC
- 0173-0881
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- mepolizumab
- Labeler
- GlaxoSmithKline LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20151104
- Source listing expiry
- 20261231
Source-listed ingredients
- MEPOLIZUMAB — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0173-0881-01) / 1 mL in 1 VIAL · 0173-0881-01
- 1 VIAL in 1 CARTON (0173-0881-61) / 1 mL in 1 VIAL · 0173-0881-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →